Amylyx Pharmaceuticals
EU regulator denies approval for Amylyx’s Albrioza, a potential ALS treatment
Anika Sharma
While Amylyx’s ALS drug, known as Albrioza in Europe and Relyvrio in the US, has made significant strides in the ...
Amylyx Pharmaceuticals Shines with ALS Drug’s Relyvrio’s Strong Performance and Promising Path Forward
SG Tylor
Amylyx Pharmaceuticals continues to impress the financial world with its amyotrophic lateral sclerosis (ALS) drug, Relyvrio. The medication, known by ...
Regulatory Update: Amylyx’s ALS drug faces rejection by the European Medicines Agency (EMA)
SG Tylor
Source – Amylyx Pharmaceuticals On June 23, 2023, the European Medicines Agency (EMA) has formally issued a negative opinion regarding ...
